Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAlliance Pharma Share News (APH)

Share Price Information for Alliance Pharma (APH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 33.50
Bid: 33.30
Ask: 33.50
Change: 0.20 (0.60%)
Spread: 0.20 (0.601%)
Open: 33.40
High: 33.60
Low: 32.50
Prev. Close: 33.30
APH Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON BROKER RATINGS: Barclays cuts United Utilities and Severn Trent

Thu, 28th Sep 2023 09:07

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning:

----------

FTSE 100

----------

Stifel cuts Burberry price target to 2,400 (2,500) pence - 'buy'

----------

Kepler Cheuvreux cuts Burberry price target to 2,100 (2,200) pence - 'hold'

----------

Deutsche Bank research cuts Croda price target to 5,200 (5,600) pence - 'hold'

----------

Goldman Sachs cuts Entain price target to 1,450 (1,680) pence - 'buy'

----------

Goldman Sachs raises Informa price target to 1,004 (986) pence - 'buy'

----------

Barclays cuts United Utilities to 'equal weight' (overweight) - price target 1,290 (1,310) pence

----------

Barclays raises Severn Trent to 'overweight' (equal weight) - price target 3,360 (3,400) pence

----------

Barclays reinitiates National Grid with 'overweight' - price target 1,300 pence

----------

Bank of America cuts Smiths Group price target to 2,020 (2,060) pence - 'buy'

----------

FTSE 250

----------

Berenberg cuts Ceres Power price target to 1,025 (1,140) pence - 'buy'

----------

Barclays cuts Pennon price target to 1,090 (1,200) pence - 'overweight'

----------

JPMorgan cuts Drax price target to 740 (830) pence - 'overweight'

----------

Jefferies cuts Volution price target to 450 (490) pence - 'buy'

----------

Jefferies raises Essentra price target to 265 (255) pence - 'buy'

----------

SMALL CAP

----------

Berenberg cuts Kistos price target to 475 (480) pence - 'buy'

----------

Berenberg starts Macfarlane group with 'buy' - price target 145 pence

----------

Citigroup cuts Asos price target to 570 (600) pence - 'buy'

----------

Berenberg cuts Alliance Pharma price target to 90 (100) pence - 'buy'

----------

JPMorgan cuts Kerry Group price target to 100 (118) EUR - 'overweight'

----------

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
9 Sep 2014 15:00

UK Earnings, Trading Statements Calendar - Week Ahead

Read more
9 Sep 2014 05:27

UK Earnings, Trading Statements Calendar - Week Ahead

Read more
8 Sep 2014 15:15

UK Earnings, Trading Statements Calendar - Week Ahead

Read more
8 Sep 2014 05:43

UK Earnings, Trading Statements Calendar - Week Ahead

Read more
5 Sep 2014 14:56

UK Earnings, Trading Statements Calendar - Week Ahead

Read more
5 Sep 2014 05:23

UK Earnings, Trading Statements Calendar - Week Ahead

Read more
4 Sep 2014 15:10

UK Earnings, Trading Statements Calendar - Week Ahead

Read more
4 Sep 2014 05:23

UK Earnings, Trading Statements Calendar - Week Ahead

Read more
3 Sep 2014 15:12

UK Earnings, Trading Statements Calendar - Week Ahead

Read more
9 Jul 2014 07:37

UK MORNING BRIEFING: Deutsche Bank Raises Shell View, Cuts BP

Read more
9 Jul 2014 07:36

Alliance Pharma Says Flat Revenue Met Its Expectations

Read more
21 May 2014 09:59

Alliance Pharma Trading In Line With Expectations

LONDON (Alliance News) - Alliance Pharma PLC Wednesday said trading in the first four months of 2014 has been in line with expectations, following a robust trading performance in 2013. In a statement released ahead of its annual general meeting Wednesday the speciality pharmaceutical compan

Read more
21 May 2014 08:36

Wednesday broker round-up UPDATE

African Minerals: Citi reduces target price from 260p to 190p, while leaving its buy recommendation unchanged. Alliance Pharma: Numis lowers target price from 39p to 37p and maintains an add rating. APR Energy: JP Morgan shifts target price from 1082p to 1089p keeping its overweight rating. Astra

Read more
26 Mar 2014 16:09

Alliance Pharma's 2013 pre-tax profit rises

Alliance Pharma's annual pre-tax profit gained 11 per cent to 12m pounds, on the back of three acquisitions. The pharmaceutical company reported a 1.4% rise in revenue to £45.5m and a 6% increase in earnings per share to 3.82p. The company said growth was "underpinned by the continuing success o

Read more
26 Mar 2014 12:53

Alliance Pharma Lifts Its 2013 Dividend As Profit And Margins Rise

LONDON (Alliance News) - Alliance Pharma PLC raised its dividend as it saw pretax profit rise in 2013, benefiting from improved margins and growth in its Hydromol dermatology range. Alliance Pharma declared Wednesday a final dividend of 0.605 pence per share, bringing its total dividend for

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.